Debunking the ETF liquidity myth

July 02, 2019

There’s more to determining an ETF’s liquidity than just looking at its trading volume


New cannabis ETF only for those ready for high risk

May 22, 2019

Horizons ETFs Management has launched a new ETF for investors to take advantage of marijuana volatility through shorting the market. Mark Noble, senior vice-president of ETF strategy at Horizons ETFs Management, joins BNN Bloomberg to discuss the new ETF. He says while there's great opportunity here for investors, it's only for those ready for high risk and short-term trading.


‘Sell in May and go away’ strategy has much merit

May 01, 2019

Brooke Thackray, Research Analyst, Horizons ETFs Management (Canada Inc.), highlights historical data that shows why the “sell in May and go away” strategy is a potentially viable option for investors and advisors.


The Case For Institutional ETFs

April 30, 2019
Joe Hornyak, Executive Editor of Benefits and Pensions Monitor, leads a roundtable discussion of ETFs with Justin Oliver, Director of Institutional ETFs for BMO; Guy Lamontagne, Vice-president and Chief Investment Strategist at Desjardins Global Asset Management; and Jaime Purvis, Executive Vice-President at Horizons ETFs.

Horizons debuts new US pot ETF

April 16, 2019

Competition for the US weed market is smoking hot after Horizons ETFs announced it had filed its final prospectus to launch the Horizons US Marijuana Index ETF.


Investors’ rising interest in cannabis puts advisors in a tough spot

April 22, 2019

Adam Hennick, an investment advisor at Mackie Research Capital Corp. in Toronto, has been fielding many questions from clients lately about Canadian holdings in their portfolio. But their inquiries haven’t been about the stumbling energy sector or whether the big banks are still good investments. Rather, they’re asking about cannabis.


Oil rises above US$70 on Libya turmoil

April 10, 2019

Military action and sanctions push prices to a 2019 high, but Morningstar analysts argue that supply and demand looks well-balanced


Is a new day dawning for ETFs in Canada?

April 08, 2019

ETFs notched a quiet, but telling, victory by outselling mutual funds in Canada in 2018. It’s a development many outside the space may not have anticipated. However, advisors familiar with the considerable advantages held by ETFs over mutual funds, particularly at a stage in the economic cycle in which unpredictability reigns (and reins-in growth expectations), see the surge in ETF interest as only the beginning.


Why now is the time for investors to go for gold

March 14, 2019

Gold is trending again … but is it a traditional reaction to increased market uncertainty or is it a sign of a brighter long-term future for the yellow metal?


Is cannabis Big Pharma’s latest drug?

March 14, 2019

With the medical marijuana market expected to hit US$ 40 billion by 2024, and the potential for cannabis compounds to displace opiates, traditional drugmakers are betting big on weed


Commissions, management fees and expenses all may be associated with an investment in exchange traded products managed by Horizons ETFs Management (Canada) Inc. (the "Horizons Exchange Traded Products"). The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing.

The Horizons Exchange Traded Products include our BetaPro products (the “BetaPro Products”). The BetaPro Products are alternative mutual funds within the meaning of National Instrument 81-102 Investment Funds, and are permitted to use strategies generally prohibited by conventional mutual funds: the ability to invest more than 10% of their net asset value in securities of a single issuer, to employ leverage, and engage in short selling to a greater extent than is permitted in conventional mutual funds. While these strategies will only be used in accordance with the investment objectives and strategies of the BetaPro Products, during certain market conditions they may accelerate the risk that an investment in units of a BetaPro Product decreases in value. The BetaPro Products consist of our 2x Daily Bull and 2x Daily Bear ETFs (“2x Daily ETFs”), Inverse ETFs (“Inverse ETFs”) and our BetaPro S&P 500 VIX Short-Term Futures™ ETF (the “VIX ETF”). Included in the 2x Daily ETFs and the Inverse ETFs are the BetaPro Marijuana Companies 2x Daily Bull ETF (“HMJU”) and BetaPro Marijuana Companies Inverse ETF (“HMJI”), which track the North American MOC Marijuana Index (NTR) and North American MOC Marijuana Index (TR), respectively. The 2x Daily ETFs and certain other BetaPro Products use leveraged investment techniques that can magnify gains and losses and may result in greater volatility of returns. These BetaPro Products are subject to leverage risk and may be subject to aggressive investment risk and price volatility risk, among other risks, which are described in their respective prospectuses. Each 2x Daily ETF seeks a return, before fees and expenses, that is either 200% or –200% of the performance of a specified underlying index, commodity futures index or benchmark (the “Target”) for a single day. Each Inverse ETF seeks a return that is –100% of the performance of its Target. Due to the compounding of daily returns a 2x Daily ETF’s or Inverse ETF’s returns over periods other than one day will likely differ in amount and, particularly in the case of the 2x Daily ETFs, possibly direction from the performance of their respective Target(s) for the same period. Hedging costs charged to BetaPro Products reduce the value of the forward price payable to that ETF. Due to the high cost of borrowing the securities of marijuana companies in particular, the hedging costs charged to HMJI are expected to be material and are expected to materially reduce the returns of HMJI to unitholders and materially impair the ability of HMJI to meet its investment objectives. Currently, the manager expects the hedging costs to be charged to HMJI and borne by unitholders will be between 15.00% and 35.00% per annum of the aggregate notional exposure of HMJI’s forward documents. The hedging costs may increase above this range. The manager will publish, on its website, the updated monthly fixed hedging cost for HMJI for the upcoming month as negotiated with the counterparty to the forward documents, based on the then current market conditions. The VIX ETF, which is a 1x ETF, as described in the prospectus, is a speculative investment tool that is not a conventional investment. The VIX ETF’s Target is highly volatile. As a result, the VIX ETF is not intended as a stand-alone long-term investment. Historically, the VIX ETF’s Target has tended to revert to a historical mean. As a result, the performance of the VIX ETF’s Target is expected to be negative over the longer term and neither the VIX ETF nor its target is expected to have positive long-term performance. Investors should monitor their holdings in BetaPro Products and their performance at least as frequently as daily to ensure such investment(s) remain consistent with their investment strategies.

*The indicated rates of return are the historical annual compounded total returns including changes in per unit value and reinvestment of all dividends or distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The rates of return shown in the table are not intended to reflect future values of the ETF or returns on investment in the ETF. Only the returns for periods of one year or greater are annualized returns.